AAAAAA

   
Results: 1-25 | 26-50 | 51-62
Results: 1-25/62
A PHASE-I AND PHARMACOKINETIC STUDY OF CBT-1 AS A MULTIDRUG-RESISTANCE MODULATOR IN THE TREATMENT OF PATIENTS WITH ADVANCED CANCER
Authors: OLDHAM RK REID WK PREISLER HD BARNETT D
Citation: Rk. Oldham et al., A PHASE-I AND PHARMACOKINETIC STUDY OF CBT-1 AS A MULTIDRUG-RESISTANCE MODULATOR IN THE TREATMENT OF PATIENTS WITH ADVANCED CANCER, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(2), 1998, pp. 71-80
TNF-ALPHA AS A GROWTH-FACTOR IN THE MYELODYSPLASTIC SYNDROMES
Authors: PREISLER HD BURKE P KOTELNIKOV V FANNING S GAO XZ VENUGOPAL P
Citation: Hd. Preisler et al., TNF-ALPHA AS A GROWTH-FACTOR IN THE MYELODYSPLASTIC SYNDROMES, Cancer research, therapy & control, 5(4), 1998, pp. 329-336
THE RELATIONSHIP BETWEEN TUMOR PROLIFERATION AND THE RESPONSE OF MALIGNANT DISEASE TO CYTOTOXIC THERAPY - SOME LESSONS LEARNED FROM CELL-CYCLE STUDIES
Authors: PREISLER HD RAZA A
Citation: Hd. Preisler et A. Raza, THE RELATIONSHIP BETWEEN TUMOR PROLIFERATION AND THE RESPONSE OF MALIGNANT DISEASE TO CYTOTOXIC THERAPY - SOME LESSONS LEARNED FROM CELL-CYCLE STUDIES, Cancer research, therapy & control, 5(3), 1998, pp. 171
TUMOR ANGIOGENESIS AND P53 MUTATIONS - PROGNOSIS IN HEAD AND NECK-CANCER
Authors: HEGDE PU BRENSKI AC CALDARELLI DD HUTCHINSON J PANJE WR WOOD NB LEURGANS S PREISLER HD TAYLOR SG CALDARELLI L COON JS
Citation: Pu. Hegde et al., TUMOR ANGIOGENESIS AND P53 MUTATIONS - PROGNOSIS IN HEAD AND NECK-CANCER, Archives of otolaryngology, head & neck surgery, 124(1), 1998, pp. 80-85
CYTOKINE GENE ACTIVITY IN AML CELLS IN-VIVO IN PATIENTS
Authors: GAO XZ BI SC COPRA H DEVEMY E VENUGOPAL P LI BR HSU WT LOEW J GALVEZ A GREGORY S YANG J HORVATH E PREISLER HD
Citation: Xz. Gao et al., CYTOKINE GENE ACTIVITY IN AML CELLS IN-VIVO IN PATIENTS, Leukemia research, 22(5), 1998, pp. 429-438
REGULATORS OF PROLIFERATION AND APOPTOSIS IN CARCINOMA OF THE LARYNX
Authors: WHISLER LC WOOD NB CALDARELLI DD HUTCHINSON JC PANJE WR FRIEDMAN M PREISLER HD LEURGANS S NOWAK J COON JS
Citation: Lc. Whisler et al., REGULATORS OF PROLIFERATION AND APOPTOSIS IN CARCINOMA OF THE LARYNX, The Laryngoscope, 108(5), 1998, pp. 630-638
ACCURACY OF HISTONE H3 MESSENGER-RNA IN-SITU HYBRIDIZATION FOR THE ASSESSMENT OF CELL-PROLIFERATION IN HUMAN TISSUES
Authors: KOTELNIKOV V CASS L COON JS SPAULDING D PREISLER HD
Citation: V. Kotelnikov et al., ACCURACY OF HISTONE H3 MESSENGER-RNA IN-SITU HYBRIDIZATION FOR THE ASSESSMENT OF CELL-PROLIFERATION IN HUMAN TISSUES, Clinical cancer research, 3(5), 1997, pp. 669-673
CYCLIN D1 EXPRESSION IN SQUAMOUS-CELL CARCINOMAS OF THE HEAD AND NECKAND IN ORAL-MUCOSA IN RELATION TO PROLIFERATION AND APOPTOSIS
Authors: KOTELNIKOV VM COON JS MUNDLE S KELANIC S LAFOLLETTE S TAYLOR S HUTCHINSON J PANJE W CALDARELLI DD PREISLER HD
Citation: Vm. Kotelnikov et al., CYCLIN D1 EXPRESSION IN SQUAMOUS-CELL CARCINOMAS OF THE HEAD AND NECKAND IN ORAL-MUCOSA IN RELATION TO PROLIFERATION AND APOPTOSIS, Clinical cancer research, 3(1), 1997, pp. 95-101
CYTOLYTIC ACTIVITY OF PERIPHERAL-BLOOD BLAST CELLS FROM PATIENTS WITHACUTE MYELOID-LEUKEMIA
Authors: BRAUN DP PREISLER HD
Citation: Dp. Braun et Hd. Preisler, CYTOLYTIC ACTIVITY OF PERIPHERAL-BLOOD BLAST CELLS FROM PATIENTS WITHACUTE MYELOID-LEUKEMIA, Leukemia & lymphoma, 27(5-6), 1997, pp. 459-467
REGROWTH RESISTANCE AS A LIKELY SIGNIFICANT CONTRIBUTOR TO TREATMENT FAILURE IN DRUG-SENSITIVE NEOPLASTIC DISEASES
Authors: PREISLER HD RAZA A BONOMI P TAYLOR S LAFOLETTE S LESLIE W LINCOLN S
Citation: Hd. Preisler et al., REGROWTH RESISTANCE AS A LIKELY SIGNIFICANT CONTRIBUTOR TO TREATMENT FAILURE IN DRUG-SENSITIVE NEOPLASTIC DISEASES, Cancer investigation, 15(4), 1997, pp. 358-368
BCL-2 AND C-MYC EXPRESSION, CELL-CYCLE KINETICS AND APOPTOSIS DURING THE PROGRESSION OF CHRONIC MYELOGENOUS LEUKEMIA FROM DIAGNOSIS TO BLASTIC PHASE
Authors: HANDA H HEGDE UP KOTELNIKOV VM MUNDLE SD DONG LM BURKE P ROSE S GASKIN F RAZA A PREISLER HD
Citation: H. Handa et al., BCL-2 AND C-MYC EXPRESSION, CELL-CYCLE KINETICS AND APOPTOSIS DURING THE PROGRESSION OF CHRONIC MYELOGENOUS LEUKEMIA FROM DIAGNOSIS TO BLASTIC PHASE, Leukemia research, 21(6), 1997, pp. 479-489
CYTOKINES, MOLECULAR BIOLOGICAL ABNORMALITIES, AND ACUTE MYELOGENOUS LEUKEMIA
Authors: PREISLER HD BI S VENUGOPAL P RAZA A
Citation: Hd. Preisler et al., CYTOKINES, MOLECULAR BIOLOGICAL ABNORMALITIES, AND ACUTE MYELOGENOUS LEUKEMIA, Leukemia research, 21(4), 1997, pp. 299-312
THE EFFECTS OF 13-CIS RETINOIC ACID AND INTERFERON-ALPHA IN CHRONIC MYELOGENOUS LEUKEMIA-CELLS IN-VIVO IN PATIENTS
Authors: HANDA H HEGDE UP KOTELNIKOV VM MUNDLE SD DONG LM BURKE P ROSE S HSU WT GASKIN F RAZA A PREISLER HD
Citation: H. Handa et al., THE EFFECTS OF 13-CIS RETINOIC ACID AND INTERFERON-ALPHA IN CHRONIC MYELOGENOUS LEUKEMIA-CELLS IN-VIVO IN PATIENTS, Leukemia research, 21(11-12), 1997, pp. 1087-1096
MUTATION OF P53 IN SQUAMOUS-CELL CANCER OF THE HEAD AND NECK - RELATIONSHIP TO TUMOR-CELL PROLIFERATION
Authors: WOOD NB KOTELNIKOV V CALDARELLI DD HUTCHINSON J PANJE WR HEDGE P LEURGANS S LAFOLLETTE S TAYLOR SG PREISLER HD COON JS
Citation: Nb. Wood et al., MUTATION OF P53 IN SQUAMOUS-CELL CANCER OF THE HEAD AND NECK - RELATIONSHIP TO TUMOR-CELL PROLIFERATION, The Laryngoscope, 107(6), 1997, pp. 827-833
EQUIVALENCE OF HISTONE H3 IN-SITU HYBRIDIZATION (HHISH) AND INTRAVENOUS ADMINISTRATION OF IUDR BRDU FOR ESTIMATING THE PERCENT OF S-PHASE CELLS IN NON-HODGKINS-LYMPHOMA (NHL)/
Authors: CHOPRA HK VENUGOPAL P KOTELNIKOV V SIVARAMAN S RILEY MB MEYER P LOEW J GREGORY SA RAZA A PREISLER HD
Citation: Hk. Chopra et al., EQUIVALENCE OF HISTONE H3 IN-SITU HYBRIDIZATION (HHISH) AND INTRAVENOUS ADMINISTRATION OF IUDR BRDU FOR ESTIMATING THE PERCENT OF S-PHASE CELLS IN NON-HODGKINS-LYMPHOMA (NHL)/, Blood, 90(10), 1997, pp. 3814-3814
EFFECTS OF IN-VIVO ADMINISTRATION OF INTERLEUKIN-4 (IL-4) TO PATIENTSWITH MYELOID LEUKEMIAS
Authors: VENUGOPAL P RAZA A JAJEH A GREGORY SA GEZER S CLOUTIER D CHOPRA HK MUNDLE S SIVARAMAN S YANG J PREISLER HD
Citation: P. Venugopal et al., EFFECTS OF IN-VIVO ADMINISTRATION OF INTERLEUKIN-4 (IL-4) TO PATIENTSWITH MYELOID LEUKEMIAS, Blood, 90(10), 1997, pp. 3856-3856
RESULTS OF A NOVEL CHEMOTHERAPY REGIMEN FOR LOW-GRADE (LGNHL) AND INTERMEDIATE GRADE (IGNHL) NON-HODGKINS-LYMPHOMA BASED ON REGROWTH RESISTANCE
Authors: VENUGOPAL P RILEY MB JAJEH A MUIASAI T MEANS L WOOCK S SHAHIDI H ADLER SS PREISLER HD GREGORY SA
Citation: P. Venugopal et al., RESULTS OF A NOVEL CHEMOTHERAPY REGIMEN FOR LOW-GRADE (LGNHL) AND INTERMEDIATE GRADE (IGNHL) NON-HODGKINS-LYMPHOMA BASED ON REGROWTH RESISTANCE, Blood, 90(10), 1997, pp. 3980-3980
DETECTION OF TELOMERASE ACTIVITY IN SECONDARY HEMATOLOGIC DISORDER BYSEMIQUANTITATIVE TRAP ASSAY
Authors: LI B YANG J BI S ANDREWS C HORVATH E TOOFANFARD P CHOPRA H DEVEMY E HUANG X RAZA A PREISLER HD
Citation: B. Li et al., DETECTION OF TELOMERASE ACTIVITY IN SECONDARY HEMATOLOGIC DISORDER BYSEMIQUANTITATIVE TRAP ASSAY, Blood, 90(10), 1997, pp. 2222-2222
AGGRESSIVE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN NEWLY-DIAGNOSED AND RELAPSED LOW-GRADE NON-HODGKINS-LYMPHOMA - PRELIMINARY-RESULTS
Authors: VENUGOPAL P GREGORY SA KAIZER H SHOWEL JL RILEY MB JAJEH A RIFKIN S ROBIN E RAZA A PREISLER HD
Citation: P. Venugopal et al., AGGRESSIVE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN NEWLY-DIAGNOSED AND RELAPSED LOW-GRADE NON-HODGKINS-LYMPHOMA - PRELIMINARY-RESULTS, Journal of investigative medicine, 44(7), 1996, pp. 395-395
CONTINUED MALIGNANT-CELL PROLIFERATION IN HEAD AND NECK TUMORS DURINGCYTOTOXIC THERAPY
Authors: PREISLER HD KOTELNIKOV VM LAFOLLETTE S TAYLOR S MUNDLE S WOOD N COON JS HUTCHINSON J PANJE W CALDARELLI DD GRIEM K
Citation: Hd. Preisler et al., CONTINUED MALIGNANT-CELL PROLIFERATION IN HEAD AND NECK TUMORS DURINGCYTOTOXIC THERAPY, Clinical cancer research, 2(9), 1996, pp. 1453-1460
PROLIFERATION OR EPITHELIA OF NONINVOLVED MUCOSA IN PATIENTS WITH HEAD AND NECK-CANCER
Authors: KOTELNIKOV VM COON JS TAYLOR S HUTCHINSON J PANJE W CALDARELLI DD LAFOLLETTE S PREISLER HD
Citation: Vm. Kotelnikov et al., PROLIFERATION OR EPITHELIA OF NONINVOLVED MUCOSA IN PATIENTS WITH HEAD AND NECK-CANCER, Head & neck, 18(6), 1996, pp. 522-528
ACCURACY OF IMMUNOHISTOCHEMISTRY AND FLOW-CYTOMETRY IN ESTIMATING THEPROPORTION OF LEUKEMIC-CELLS IN S-PHASE IN CHRONIC MYELOID-LEUKEMIA PATIENTS
Authors: HEGDE U KOTELNIKOV VM HANDA H BURKE P PREISLER HD
Citation: U. Hegde et al., ACCURACY OF IMMUNOHISTOCHEMISTRY AND FLOW-CYTOMETRY IN ESTIMATING THEPROPORTION OF LEUKEMIC-CELLS IN S-PHASE IN CHRONIC MYELOID-LEUKEMIA PATIENTS, Leukemia & lymphoma, 22(5-6), 1996, pp. 431
ASSESSMENT OF APOPTOSIS IN RELATION TO PROLIFERATION AND MUTATIONAL STATUS OF P53 GENE IN HEAD AND NECK CANCERS
Authors: MUNDLE SD KOTELNIKOV VM WOOD NB COON JS HORVATH E TAYLOR SG LAFOLLETTE S CALDARELLI DD HUTCHINSON JC PANJE WR PREISLER HD RAZA A
Citation: Sd. Mundle et al., ASSESSMENT OF APOPTOSIS IN RELATION TO PROLIFERATION AND MUTATIONAL STATUS OF P53 GENE IN HEAD AND NECK CANCERS, International journal of oncology, 8(6), 1996, pp. 1257-1264
ENZYMATIC PROGRAMMING OF APOPTOTIC CELL-DEATH
Authors: MUNDLE SD GREGORY SA PREISLER HD RAZA A
Citation: Sd. Mundle et al., ENZYMATIC PROGRAMMING OF APOPTOTIC CELL-DEATH, Pathobiology, 64(3), 1996, pp. 161-170
EFFECTS OF 13 CIS-RETINOIC ACID AND ALPHA-INTERFERON (RA IFN) ON CML CELLS IN-VIVO - DIFFERENCES BETWEEN B3A2 AND B2A2 CML/
Authors: PREISLER HD GAO XZ HANDA H HEGDE U KOTELNIKOV V RAZA A
Citation: Hd. Preisler et al., EFFECTS OF 13 CIS-RETINOIC ACID AND ALPHA-INTERFERON (RA IFN) ON CML CELLS IN-VIVO - DIFFERENCES BETWEEN B3A2 AND B2A2 CML/, Experimental hematology, 24(9), 1996, pp. 591-591
Risultati: 1-25 | 26-50 | 51-62